Endymed Expands Its Operation in North America

Welcomes Bill Scott as Endymed's US Subsidiary President

Endymed Ltd (TASE: ENDY), currently traded on Tel Aviv Stock Exchange, is pleased to announce the appointment of Bill Scott as President of its US subsidiary, Endymed Inc.

As president of Endymed Inc. Bill will be responsible for leading Endymed’s sales teams in the United States, ensuring customers receive the highest standards of sales and account management support. Mr. Scott was selected to lead the Company’s operations in the United States and Canada as part of the Company’s growth plan of expanding its operations in North America, and in particular the United States. With experience spanning over 25 years in the medical esthetics field, Bill’s leadership and expertise will be invaluable to Endymed’s growth.

A dynamic leader providing support designed for success and growth within the organization. Bill strategically focused on increasing productivity that benefits the bottom-line. Bill possess a deep passion for sales in the aesthetic and surgical arena while developing relationships that promotes long-term progress. While at Palomar Medical, he served as West U.S. and Canada Sales Director. Bill’s team was consistently recognized as the #1 region in sales. In 2013, Bill was recruited as North American VP of Sales at Alma. After rebuilding and stabilizing the sales force, the company attained annual double-digit growth achieving a successful IPO launch in 2017 – more than doubling its valuation. . Most recently, as VP North America Sales at Viora Medical, Bill supported historic revenue growth that followed with an acquisition resulting from success in the U.S. market.

Bill’s proven core competencies include team turnaround leadership focused on sales revenue, sales training, team building & new product launches. Bill is motivated to continue the excellence at Endymed and supporting the team in building a world-class sales organization. The Company believes that the joining of Mr. Scott will drive its US growth plan and help secure a significant reach in the North American market.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Chistine Senn will serve as Chair of the Site-Sponsor Consortium – a collaborative body now in its second year – and as Chair of Advarra's Customer Advisory Board. She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
Christopher Slachta joins Cytovale after serving 12 years at Abbott, most recently as divisional vice president of global operations and supply chain, molecular diagnostics.
Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.

By using this website you agree to accept Medical Device News Magazine Privacy Policy